Short-course treatment of community-acquired pneumonia

被引：29

作者：

Mandell, LA

File, TM

机构：

[1] Henderson Gen Hosp, Hamilton, ON L8V 1C3, Canada

[2] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Rootstown, OH 44272 USA

[3] Summa Hlth Syst, Akron, OH USA

来源：

CLINICAL INFECTIOUS DISEASES | 2003年 / 37卷 / 06期

关键词：

D O I：

10.1086/377567

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：761 / 763

页数：3

共 10 条

[1] Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia [J].

Dennesen, PJW ;

van der Ven, AJAM ;

Kessels, AGH ;

Ramsay, C ;

Bonten, MJM .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (06) :1371-1375

[2] High-dose, short-course Levofloxacin for community-acquired pneumonia: A new treatment paradigm [J].

Dunbar, LM ;

Wunderink, RG ;

Habib, MP ;

Smith, LG ;

Tennenberg, AM ;

Khashab, MM ;

Wiesinger, BA ;

Xiang, JX ;

Zadeikis, N ;

Kahn, JB .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (06) :752-760

[3] Seady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects [J].

Gotfried, MH ;

Danzinger, LH ;

Rodvold, KA .

CHEST, 2001, 119 (04) :1114-1122

[4] A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome [J].

Hoepelman, IM ;

Mollers, MJ ;

van Schie, MH ;

Greefhorst, APM ;

Schlosser, NJJ ;

Damste, EJS ;

van de Moosdijk, CNF ;

Dalinghaus, WH ;

Eland, ME ;

Mol, SJM ;

Rozenberg-Arska, M .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1998, 9 (03) :141-146

[5] Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae [J].

Lister, PD .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 44 (01) :43-49

[6] Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome [J].

Luna, CM ;

Blanzaco, D ;

Niederman, MS ;

Matarucco, W ;

Baredes, NC ;

Desmery, P ;

Palizas, F ;

Menga, G ;

Rios, F ;

Apezteguia, C .

CRITICAL CARE MEDICINE, 2003, 31 (03) :676-682

[7] Randomized, multicentre study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of adults with mild to moderate community-acquired pneumonia [J].

O'Doherty, B ;

Muller, O .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (12) :828-833

[8] Pharmacodynamics of levofloxacin - A new paradigm for early clinical trials [J].

Preston, SL ;

Drusano, GL ;

Berman, AL ;

Fowler, CL ;

Chow, AT ;

Dornseif, B ;

Reichl, V ;

Natarajan, J ;

Corrado, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (02) :125-129

[9] Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage -: A randomized trial [J].

Schrag, SJ ;

Peña, C ;

Fernández, J ;

Sánchez, J ;

Gómez, V ;

Pérez, E ;

Feris, JM ;

Besser, RE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :49-56

[10]

TELLIER G, 2002, 42 INT C ANT AG CHEM, P346

← 1 →